Document Detail


Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial.
MedLine Citation:
PMID:  19110789     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: The aim of this study was to evaluate the effectiveness of titanium-nitride-oxide (TITANOX)-coated stent and paclitaxel-eluting stent (PES) in patients presenting with acute myocardial infarction (MI). METHODS AND RESULTS: A total of 425 patients presenting with acute non-ST-elevation MI or ST-elevation MI were randomly assigned to receive TITANOX-coated stent or PES. The primary end point was a composite of MI, target lesion revascularisation (TLR) or death from cardiac causes. At 12 months, there was no significant difference between patients receiving TITANOX-coated stent or PES in the rates of primary end point (10.3% vs. 12.8%, P=0.5), MI (4.2% vs. 8.1%, P=0.1), or TLR (9.3% vs. 7.1%, P=0.5), respectively. The incidence of stent thrombosis, defined according to Academic Research Consortium classification, was significantly lower in the TITANOX group compared to the PES group (0.9% vs. 4.3%, P=0.03). CONCLUSIONS: TITANOX-coated stent and PES resulted in comparable clinical outcomes during 12 months follow-up among patients treated for acute MI.
Authors:
Pasi P Karjalainen; Antti Ylitalo; Matti Niemelä; Kari Kervinen; Timo Mäkikallio; Mikko Pietili; Jussi Sia; Petri Tuomainen; Kai Nyman; K E Juhani Airaksinen
Related Documents :
8840839 - Intracoronary stent implantation without ultrasound guidance and with replacement of co...
12403899 - Recurrent myocardial infarction due to obstruction of the rca ostium by an aortic papil...
1746219 - Vertebral artery tortuosity with concomitant erosion of the foramen of the transverse p...
9308219 - Vascular claudication: how to individualize treatment.
12943879 - Peripheral vascular disease and one-year mortality following percutaneous coronary reva...
21285459 - Use of the impella 2.5 in high-risk percutaneous coronary intervention.
7867179 - Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 2...
9561999 - Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking age...
1464239 - Diastolic heart failure.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  4     ISSN:  1774-024X     ISO Abbreviation:  -     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-12-29     Completed Date:  2009-02-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  234-41     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Satakunta Central Hospital, Pori, Finland. pasi.karjalainen@satshp.fi
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00495664
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angioplasty, Transluminal, Percutaneous Coronary*
Antineoplastic Agents, Phytogenic / administration & dosage
Disease-Free Survival
Drug-Eluting Stents*
Female
Follow-Up Studies
Humans
Incidence
Male
Middle Aged
Myocardial Infarction / epidemiology,  therapy*
Paclitaxel / administration & dosage*
Recurrence
Risk Factors
Thrombosis / prevention & control
Titanium*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 0/titanium-nitride-oxide; 33069-62-4/Paclitaxel; 7440-32-6/Titanium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcat...
Next Document:  Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third gen...